The company’s protein-based vaccine showed strong efficacy over time, and it reported $1.1 billion in revenue in 2021.
Category: alexknappblog
Covid-19 Stalks The Battlefields Of Ukraine
Less than 35% of the country’s population is fully vaccinated, and Covid-19 treatments will be harder to access in the middle of a war zone.
Benchling Expands Its Science Software Capabilities With Its First Acquisition
The cloud-based lab software company will be acquiring Belfast-based Overwatch Research, which has developed software geared towards in vivo research.
Billionaire Jared Isaacman Plans To Go Back To Space This Year
Last September, billionaire Jared Isaacman made space history with his Inspiration4 flight.
Doctors Successfully Transplanted A Gene-Edited Pig Kidney – And They Have Plans To Scale Up
The successful transplantation by scientists at University of Alabama-Birmingham into a brain-dead human body paves the way to clinical trials — and hope for thousands of patients suffering kidney disease.
Doctors Successfully Transplanted A Gene-Edited Pig Kidney – And They Have Plans To Scale Up
The successful transplantation by scientists at University of Alabama-Birmingham into a brain-dead human body paves the way to clinical trials — and hope for thousands of patients suffering kidney disease.
Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery
The two companies will begin offering its combined platform product in mid-2022.
Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery
The two companies will begin offering their combined platform product in mid-2022.
Better Vaccines, New Treatments And More Tests: Healthcare Companies Reveal Covid Plans
Pfizer, Moderna, Regeneron and many other healthcare companies presented at the 40th annual J.P. Morgan Healthcare Conference and outlined their plans to continue fighting Covid this year.
Digital Health Startup Transcarent Just Raised $200 Million To Grow Its Concierge Medical Business
The company, helmed by former Livongo CEO Glen Tullman, just raised a series C round at a $1.6 billion valuation.
